AXIO BIOSOLUTIONS

Axio is a medtech R&D and Manufacturing Company focused on Advanced Surgical and wound care. Axio has the distinction to be the first company from India to get USFDA clearance for a woundcare/hemostat product. Controlling life threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat is its flagship product developed to reduce the mortality due to traumatic bleeding. A CE approved product, Axiostat is based on a patented novel 100% chitosan platform and has variants catering to Emergency & Trauma, Military, Cardio-vascular and Dental applications.